| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:1750-1754.)
© 1997 American Heart Association, Inc.
Articles |
Long-term Instability of Fasting Plasma Glucose, a Novel Predictor of Cardiovascular Mortality in Elderly Patients With Non–Insulin-Dependent Diabetes Mellitus
The Verona Diabetes Study
From the Division of Endocrinology and Metabolic Diseases (M.M., E.B., G.Z., M.C.) and the Division of Medical Statistics (G.V., R. de M.), University of Verona, Italy.
Correspondence to Prof Michele Muggeo, Divisione di Endocrinologia e Malattie del Metabolismo, Ospedale Civile Maggiore, Piazzale Stefani, 1, 37126 Verona, Italy.
Background We recently reported that long-term fasting plasma glucose (FPG) instability predicts all-cause mortality in elderly patients with non–insulin-dependent diabetes mellitus (NIDDM). The aim of the present study was to evaluate whether glucose instability, as represented by the coefficient of variation of FPG concentrations (CV-FPG) measured during a 3-year period, can predict specific causes of death in the subsequent 5 years.
Methods and Results Five hundred sixty-six elderly patients with NIDDM were followed up for 5 years to assess mortality and causes of death. All FPG determinations of the 3 years preceding the follow-up available in the clinical records were collected and analyzed. Patients were grouped in tertiles of mean FPG, CV-FPG, and the slope of FPG. These parameters of glucose control, as well as sex, age, duration of diabetes, insulin treatment, cigarette smoking, hypertension, and total cholesterol, were included in a multivariate analysis of mortality. During the follow-up, 63 men and 128 women died. Diabetes- and malignancy-related mortality were not independently associated with any parameter of glucose control, whereas cardiovascular-related mortality was independently associated with CV-FPG (P=.007) but not with the mean or the slope of FPG. In particular, the relative risk of cardiovascular mortality in subjects in tertile III versus tertile I of CV-FPG was 2.40 (95% CI, 1.28 to 4.53).
Conclusions These results indicate that FPG instability is a predictor of cardiovascular-related mortality in elderly patients with NIDDM and suggest that glucose stability might be a goal in the management of these patients.
Key Words: diabetes mellitus • metabolism • mortality • aging • glucose • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  A. Ceriello, K. Esposito, L. Piconi, M. A. Ihnat, J. E. Thorpe, R. Testa, M. Boemi, and D. Giugliano Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients Diabetes, May 1, 2008; 57(5): 1349 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Abbatecola, M. R. Rizzo, M. Barbieri, R. Grella, A. Arciello, M. T. Laieta, R. Acampora, N. Passariello, F. Cacciapuoti, and G. Paolisso Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology, July 25, 2006; 67(2): 235 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. B. Bolli Glucose Variability and Complications Diabetes Care, July 1, 2006; 29(7): 1707 - 1709. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cavalot, A. Petrelli, M. Traversa, K. Bonomo, E. Fiora, M. Conti, G. Anfossi, G. Costa, and M. Trovati Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ahmed, R. Babaei-Jadidi, S. K. Howell, P. J. Thornalley, and P. J. Beisswenger Glycated and Oxidized Protein Degradation Products Are Indicators of Fasting and Postprandial Hyperglycemia in Diabetes Diabetes Care, October 1, 2005; 28(10): 2465 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R G. Barr, D. M. Nathan, J. B. Meigs, and D. E. Singer Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus Ann Intern Med, August 20, 2002; 137(4): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, et al. HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective data from the Verona Diabetes Complications Study Diabetes Care, July 1, 2002; 25(7): 1135 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Risso, F. Mercuri, L. Quagliaro, G. Damante, and A. Ceriello Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E924 - E930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J Jarrett, E. Lamb, K.-T. Khaw, N. Wareham, and V. Vlassov Glycated haemoglobin, diabetes, and mortality in men BMJ, April 21, 2001; 322(7292): 996 - 996. [Full Text]
|
|
|
|
 |
|
 J. R. Kersten, M. W. Montgomery, T. Ghassemi, E. R. Gross, W. G. Toller, P. S. Pagel, and D. C. Warltier Diabetes and hyperglycemia impair activation of mitochondrial KATP channels Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1744 - H1750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wei, L. W. Gibbons, T. L. Mitchell, J. B. Kampert, M. P. Stern, and S. N. Blair Low Fasting Plasma Glucose Level as a Predictor of Cardiovascular Disease and All-Cause Mortality Circulation, May 2, 2000; 101(17): 2047 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kersten, W. G. Toller, E. R. Gross, P. S. Pagel, and D. C. Warltier Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1218 - H1224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kersten and D. C. Warltier Modulation of the adaptive response to myocardial ischemia by coexisting disease Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H2268 - H2270. [Full Text] [PDF]
|
|